Advertisement

Ads Placeholder
Loading...

Orexigen Therapeutics, Inc.

OREX•NASDAQ
Healthcare
Medical - Pharmaceuticals
$0.22
$0.00(0.00%)
U.S. Market opens in 5h 54m

Orexigen Therapeutics, Inc. (OREX) Stock Overview

Explore Orexigen Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.14
EPS (TTM)N/A
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

OREX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Orexigen Therapeutics, Inc. (OREX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.14 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateApr 26, 2007
CountryNaN

Frequently Asked Questions